v3.26.1
Award Timing Disclosure
 12 Months Ended
Apr. 24, 2026
Mar. 10, 2026
$ / shares
Mar. 09, 2026
USD ($)
shares
$ / shares
Mar. 06, 2026
$ / shares
Award Timing Disclosures [Line Items]        
Award Timing MNPI Disclosure
Equity Award Granting Practices
Equity awards for MiniMed NEOs and other employees are approved by MiniMed’s Board or the appropriate committee or sub-committee on or before the date of grant. It is MiniMed’s general practice to grant annual equity awards in July of each year. Equity awards may also be granted outside of MiniMed’s annual grant cycle for new hires, promotions, retention, or other purposes. MiniMed does not permit the timed disclosure of material non-public information for the purpose of affecting the value of executive compensation.
The following table contains information required by Item 402(x)(2) of Regulation S-K regarding stock options granted to MiniMed’s NEOs in fiscal year 2026, during the period from four business days before to one business day after the filing of MiniMed’s periodic reports on Forms 10-K and 10-Q, or current reports on Form 8-K that contained material non-public information. Specifically, the following table includes information regarding the IPO Grant Options granted to MiniMed’s NEOs on March 9, 2026, the closing date of MiniMed’s initial public offering.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name
 
 
Grant Date
 
 
Number of
securities
underlying
the award
(#)
 
 
Exercise
price of
the award
($/Sh)
 
 
Grant date
fair value
of the
award(1)
($)
 
 
Percentage change in
the closing market price of the
securities underlying the award
between the trading day ending
immediately prior to the
disclosure of material
nonpublic information and the
trading day beginning
immediately following the
disclosure of material
nonpublic information (2)
(%)
Que Dallara
 
 
3/9/2026
 
 
252,526
 
 
$18.00
 
 
$1,868,692
 
 
(0.9)%
Chad Spooner
 
 
3/9/2026
 
 
84,176
 
 
$18.00
 
 
$622,902
 
 
(0.9)%
Ali Dianaty
 
 
3/9/2026
 
 
126,263
 
 
$18.00
 
 
$934,346
 
 
(0.9)%
Courtney Nelson Wills
 
 
3/9/2026
 
 
63,132
 
 
$18.00
 
 
$467,177
 
 
(0.9)%
Gillian Chandrasena
 
 
3/9/2026
 
 
63,132
 
 
$18.00
 
 
$467,177
 
 
(0.9)%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)
This column represents the grant date fair values of the IPO Grant Options, which were calculated in accordance with FASB ASC Topic 718. Information regarding the assumptions used to calculate these amounts is incorporated by reference to Note 9, “Stock-based Compensation,” to the consolidated financial statements in MiniMed’s Annual Report on Form 10-K for fiscal year 2026.
(2)
Calculated using the closing prices of MiniMed Common Stock on March 6, 2026 and March 10, 2026, of $18.49, and $18.33, per share, respectively, relating to the filing of the Form 8-K on March 9, 2026 regarding the closing of MiniMed’s initial public offering.
     
Award Timing Method Equity awards for MiniMed NEOs and other employees are approved by MiniMed’s Board or the appropriate committee or sub-committee on or before the date of grant. It is MiniMed’s general practice to grant annual equity awards in July of each year. Equity awards may also be granted outside of MiniMed’s annual grant cycle for new hires, promotions, retention, or other purposes.      
Award Timing Predetermined true      
Award Timing, How MNPI Considered MiniMed does not permit the timed disclosure of material non-public information for the purpose of affecting the value of executive compensation.      
MNPI Disclosure Timed for Compensation Value false      
Awards Close in Time to MNPI Disclosures, Table
The following table contains information required by Item 402(x)(2) of Regulation S-K regarding stock options granted to MiniMed’s NEOs in fiscal year 2026, during the period from four business days before to one business day after the filing of MiniMed’s periodic reports on Forms 10-K and 10-Q, or current reports on Form 8-K that contained material non-public information. Specifically, the following table includes information regarding the IPO Grant Options granted to MiniMed’s NEOs on March 9, 2026, the closing date of MiniMed’s initial public offering.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name
 
 
Grant Date
 
 
Number of
securities
underlying
the award
(#)
 
 
Exercise
price of
the award
($/Sh)
 
 
Grant date
fair value
of the
award(1)
($)
 
 
Percentage change in
the closing market price of the
securities underlying the award
between the trading day ending
immediately prior to the
disclosure of material
nonpublic information and the
trading day beginning
immediately following the
disclosure of material
nonpublic information (2)
(%)
Que Dallara
 
 
3/9/2026
 
 
252,526
 
 
$18.00
 
 
$1,868,692
 
 
(0.9)%
Chad Spooner
 
 
3/9/2026
 
 
84,176
 
 
$18.00
 
 
$622,902
 
 
(0.9)%
Ali Dianaty
 
 
3/9/2026
 
 
126,263
 
 
$18.00
 
 
$934,346
 
 
(0.9)%
Courtney Nelson Wills
 
 
3/9/2026
 
 
63,132
 
 
$18.00
 
 
$467,177
 
 
(0.9)%
Gillian Chandrasena
 
 
3/9/2026
 
 
63,132
 
 
$18.00
 
 
$467,177
 
 
(0.9)%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)
This column represents the grant date fair values of the IPO Grant Options, which were calculated in accordance with FASB ASC Topic 718. Information regarding the assumptions used to calculate these amounts is incorporated by reference to Note 9, “Stock-based Compensation,” to the consolidated financial statements in MiniMed’s Annual Report on Form 10-K for fiscal year 2026.
(2)
Calculated using the closing prices of MiniMed Common Stock on March 6, 2026 and March 10, 2026, of $18.49, and $18.33, per share, respectively, relating to the filing of the Form 8-K on March 9, 2026 regarding the closing of MiniMed’s initial public offering.
     
Awards Close in Time to MNPI Disclosures        
Share Price   $ 18.33   $ 18.49
Que Dallara [Member]        
Awards Close in Time to MNPI Disclosures        
Name     Que Dallara  
Underlying Securities | shares     252,526  
Exercise Price     $ 18  
Fair Value as of Grant Date | $     $ 1,868,692  
Underlying Security Market Price Change     (0.009)  
Chad Spooner [Member]        
Awards Close in Time to MNPI Disclosures        
Name     Chad Spooner  
Underlying Securities | shares     84,176  
Exercise Price     $ 18  
Fair Value as of Grant Date | $     $ 622,902  
Underlying Security Market Price Change     (0.009)  
Ali Dianaty [Member]        
Awards Close in Time to MNPI Disclosures        
Name     Ali Dianaty  
Underlying Securities | shares     126,263  
Exercise Price     $ 18  
Fair Value as of Grant Date | $     $ 934,346  
Underlying Security Market Price Change     (0.009)  
Courtney Nelson Wills [Member]        
Awards Close in Time to MNPI Disclosures        
Name     Courtney Nelson Wills  
Underlying Securities | shares     63,132  
Exercise Price     $ 18  
Fair Value as of Grant Date | $     $ 467,177  
Underlying Security Market Price Change     (0.009)  
Gillian Chandrasena [Member]        
Awards Close in Time to MNPI Disclosures        
Name     Gillian Chandrasena  
Underlying Securities | shares     63,132  
Exercise Price     $ 18  
Fair Value as of Grant Date | $     $ 467,177  
Underlying Security Market Price Change     (0.009)